Christopher Burns

Malvern, Pennsylvania, United States
Dr. Christopher J. Burns is President and CEO of Venatorx Pharmaceuticals, a world leader in antibacterial and antiviral drug research and development. Dr. Burns has 30 years’ experience in the pharmaceutical industry, including various corporate and R&D leadership positions at Protez/Novartis, ViroPharma, and Rhone-Poulenc Rorer (now Sanofi). Dr. Burns has appeared as co-author or co-inventor on more than 60 patents and publications and has served as Principal Investigator on more than ten awarded U.S. NIH grants. He received a B.S. in Chemistry from St. Joseph’s University, and a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology (MIT) under Nobel-laureate Professor K. Barry Sharpless. Dr. Burns currently serves on the Board of Directors at LSPA and AWG and is on the Advisory Board for Life Science Cares Philadelphia. Dr. Burns was named both Life Sciences Pennsylvania’s ‘CEO of the Year’ and an Ernst and Young ‘Entrepreneur of the Year’ in 2019.
Speaking In
[Available On-Demand]
Venatorx Pharmaceuticals is a private pharmaceutical company focused on improving health outcomes…